BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 101   

Articles published

BIOL 1.69 -0.05 (-2.87%)
price chart
Biolase, Inc. Short Interest Drops by -0.1%
Biolase, Inc. (NASDAQ:BIOL), According to the latest information the short interest in Biolase, Inc. plummeted by 0.1% or 4,005 shares.
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
Biolase: Why Your Dentist Is Short This Stock
... and I find myself in wonder of how major shareholders haven't forced aggressive action to spark a turnaround. I also find myself in a position to profit from all three.
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
Related articles »  
BIOLASE Comments on Recent Decline in Stock Price
BIOLASE, Inc. is a medical device company that develops, manufactures, and markets innovative lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital imaging equipment, CAD/CAM intraoral scanners, and in-office ...
Biolase Jumps on CEO Comments  Orange County Business Journal
BIOLASE SHAREHOLDER ALERT - Andrews & Springer LLC is Investigating ...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating the Board of Directors of Biolase, Inc. ("Biolase" or the "Company") for possible corporate misconduct and violations ...
Related articles »  
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
Healthcare Stocks In The Spotlight: BIOLASE, (NASDAQ:BIOL), AmSurg ...
BIOLASE, Inc. (NASDAQ:BIOL)'s shares picked up 5.85%, and closed at $2.17, during the last trading session, soon after the news release that a medical technology company, introduced dentistry's first-ever Practice Growth Guarantee with the launch of ...
BIOLASE Announces Management Change
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today reported that Frederick D. Furry has resigned as Chief Financial Officer, effective January 31, 2015 to pursue other ...